Company intelligence / Profile preview

IlluminOss Medical

East Providence, Rhode Island, United Statesilluminoss.com ↗

Ownership: Private
Development stage: Commercial

Overview

The IlluminOss System has been CE-marked in Europe and FDA-cleared in the US for a variety of anatomical fracture indications. Over 4,000 procedures have been performed in Europe. The technology enables minimally invasive fracture repair with early mobilization and increased stability for compromised bone.

Therapeutic areas: OtherEndocrinologyRheumatology
Modalities: Device (specifically, minimally invasive orthopedic implant)Polymer-based implant technologyLight-curable polymer system (Photodynamic Bone Stabilization System)
Industry: Implantable Medical Devices

Partnerships

HealthpointCapital [investment/ownership partnership]

Beyond the preview

Go deeper on IlluminOss Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IlluminOss Medical.

Explore the full profile